DUBLIN, May 17, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Biochips Market by Type, End user, Fabrication Technology - Forecast to 2020" report to their offering.
The biochips market is forecast to reach USD 17.75 Billion by 2020 from USD 7.63 Billion in 2015, growing at a CAGR of 18.4% during the forecast period (2015-2020). Increasing adoption of personalized medicine, growing applications of biochips, and technological advancements are the major drivers for the biochips market. However, unclear regulatory guidelines, high instrumentation costs, and absolute quantification of specific mRNA may restrain the market growth to a certain extent.
In this report, the biochips market is segmented on the basis of type, application, fabrication technology, end user, and region. Based on type, the market is segmented into DNA chips, lab-on-a-chip, protein chips, and other arrays. The other arrays segment includes cell arrays and tissue arrays. Based on applications, the DNA chips segment is categorized into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, agricultural biotechnology, drug discovery, and other applications (microbial genotyping, proteomics, toxicogenomics, screening and monitoring of patient data in clinical trials, and environmental biology). Based on applications, the lab-on-a-chip segment is classified into genomics, proteomics, drug discovery, IVD & POC clinical diagnostics, and other applications (biodefense, food pathogen identification, and environmental contamination). Similarly, the protein chips market, by application, is segmented into proteomics, high-throughput screening, drug discovery, and other applications (environmental diagnostics and biodefense).
Based on end users, the biochips market is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories).Similarly, based on fabrication technology, the biochips market is segmented into microarrays and microfluidics.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Cepheid Inc.
- Fluidigm Corporation
- GE Healthcare
- Illumina, Inc.
- Perkinelmer, Inc.
- Roche Diagnostics
- Thermo Fisher Scientific, Inc.
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Biochips Market, By Type
7 Biochips Market, By Fabrication Technology
8 Biochips Market, By End User
9 Biochips Market, By Region
10 Competitive Landscape
11 Company Profiles
For more information visit http://www.researchandmarkets.com/research/7m6p8b/biochips_market
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-biochips-market-value-of-usd-1775-billion-by-2020---trends-technologies--opportunities-report-2016-2020---research-and-markets-300269769.html
SOURCE Research and Markets